CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. [electronic resource]
Producer: 20051026Description: 1619-27 p. digitalISSN:- 0022-1767
- Adjuvants, Immunologic -- pharmacology
- Adoptive Transfer
- Animals
- Antibodies, Monoclonal -- metabolism
- Antibodies, Monoclonal, Humanized
- Cell Line, Tumor
- Cells, Cultured
- CpG Islands -- immunology
- Cytokines -- biosynthesis
- Cytotoxicity, Immunologic -- immunology
- DNA-Binding Proteins -- biosynthesis
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Interferon-gamma -- biosynthesis
- Killer Cells, Natural -- immunology
- Mice
- Mice, Inbred BALB C
- Neoplasm Transplantation
- Oligodeoxyribonucleotides -- administration & dosage
- Receptors, Cell Surface -- biosynthesis
- Toll-Like Receptor 9
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.